ABOUT US
Our Story
We’ve spent years laying the scientific and technological groundwork to be the experts on the adaptive immune system. With our partners, we’ve spearheaded the discovery and development of its vast applications across healthcare —and it’s just the beginning.
OUR VISION
We aim to improve people’s lives by translating the scale and precision of their adaptive immune systems into products to diagnose, treat, and monitor disease.
Adaptive Culture
Who we are
Pioneers
We are a company of clever and collaborative individuals with distinct talents and a singular vision for translating the wisdom of the adaptive immune system with precision and at scale.
Team players
We enable leaders across various disciplines—immunology, sequencing, computational biology, and software development—to converge every day to uncover more about the adaptive immune system.
Partners
We empower our partners in the academic and biopharmaceutical communities with our platform, products, services, and data. Together, we’re helping to advance the field of immune-driven medicine.
LEADERSHIP
Uniquely equipped to achieve our bold vision
ADVISORS
ADVISORS
Jay Shendure, MD, PHD
Professor, Genome Sciences, University of Washington
Gerald T. Nepom, MD, PHD
Director, Benaroya Research Institute at Virginia Mason, Seattle; and Professor (Affiliate), Department of Immunology, University of Washington School of Medicine
Edus Houston Warren, MD, PHD
Associate Professor, University of Washington; and Associate Member, Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center
David Miklos, MD, PHD
Associate Professor (Blood and Marrow Transplantation), Stanford University Medical Center
HEMATOLOGY BOARD
Frederick R. Appelbaum, MD
Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center
Marco Davila, MD, PHD
Associate Professor, University of South Florida; and Associate Member, Moffitt Cancer Center
Rafael Fonseca, MD, PHD
Site Director, Hematological Malignancies, and Getz Family Professor of Cancer Chair, Department of Medicine, Mayo Clinic Arizona; Distinguished Mayo Investigator
Paolo Ghia, MD, PHD
Associate Professor, San Raffaele University Scientific Coordinator of the Lymphoma Unit, Department of Oncology, and principal investigator in the Laboratory of Lymphoid Malignancies at the San Raffaele Scientific Institute; Chairman, Basic & Translational Committee of the European Research Initiative on CLL (ERIC) Member, The Advisory Board for the Scientific Programme Committee of the European Hematology Association (EHA)
Thomas S. Kupper, MD
Thomas B. Fitzpatrick Professor of Dermatology, Harvard Medical School, and Chairman of Dermatology, Dermatologist in Chief Brigham and Women’s Hospital Dana Farber Cancer Institute
Richard A. Larson, MD
Professor of Medicine, Section of Hematology/Oncology Director of the Hematologic Malignancies Clinical Research Program, and Chairman of The Leukemia Committee of The Cancer and Leukemia Group B, University of Chicago
Ching-Hon Pui, MD
Chair of the Department of Oncology at St. Jude
Jerry Radich, MD
Member of the Clinical Research Division at the Fred Hutchinson Cancer Research Center; Professor of Medicine at the University of Washington
Andrew D. Zelenetz, MD, PHD
Medical Director, Quality Informatics, Memorial Sloan-Kettering Cancer Center
IMMUNO-ONCOLOGY BOARD
Robert Anders, MD, PHD
Associate Professor, Pathology, Johns Hopkins University School of Medicine
Mac Cheever, MD
Director of Solid Tumor Research, Fred Hutchinson Cancer Research Center, and Professor of Medicine/Oncology, University of Washington
F. Stephen Hodi, MD
Director, Center of Immuno-Oncology; and Sharon Crowley Martin Chair (Melanoma) Dana Farber Cancer Institute, and Professor of Medicine, Harvard Medical School
Elizabeth Jaffee, MD
Co-Director of the Division of Immunology, and Co-leader of the Gastrointestinal Cancers Program in the Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Associate Director for Translational Research at the Sidney Kimmel Cancer Center at Johns Hopkins
Hiroyoshi Nishikawa, MD, PHD
Director, Division of Cancer Immunology, National Cancer Center East Japan
Eric Pamer, MD
Chief of the Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center
Stan Riddell, MD
Scientific Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; and Professor of Oncology, University of Washington School of Medicine
Ton Schumacher, PHD
Group Leader, The Netherlands Cancer Institute
Mario Sznol, MD
Professor of Medicine (Medical Oncology), and Clinical Research Program Leader, Melanoma Program, Yale Cancer Center; Co-Director, Yale SPORE in Skin Cancer
Pierre Van Der Bruggen, PHD
Member, Ludwig Institute for Cancer Research in Brussels
Jedd Wolchok, MD, PHD
Chief, Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center; Associate Director, Ludwig Center for Cancer Immunotherapy at MSKCC
Cassian Yee, MD
Professor at the MD Anderson Cancer Center, University of Texas
Keep up to date with Adaptive.